From January 1, 2024 to March 6, 2024, the company has repurchased 1,189,100 shares, representing 0.22% for CNY 13.31 million. With this, the company has completed the repurchase of 9,307,200 shares, representing 1.7% for CNY 100 million under the buyback announced on September 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.34 CNY | -2.37% | +8.15% | +4.49% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.49% | 93Cr | |
+21.09% | 4.33TCr | |
+25.28% | 2.29TCr | |
+19.22% | 1.54TCr | |
+13.51% | 1.29TCr | |
+44.01% | 1.18TCr | |
-7.79% | 691.1Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+13.02% | 554.99Cr |
- Stock Market
- Equities
- 300401 Stock
- News Zhejiang Garden Biopharmaceutical Co.,Ltd.
- Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.